1449766-35-1Relevant articles and documents
LONG CHAIN BASE SPHINGOSINE KINASE INHIBITORS
-
Paragraph 0287, (2013/08/28)
The invention relates to inhibitors of sphingosine kinase enzymatic activity, compounds and pharmaceutical compositions that inhibit sphingosine kinase 1 and sphingosine kinase 2 (SphK1 and SphK2) enzymes and further relates to methods of treating diseases and disorders mediated by sphingosine 1 phosphate activity, comprising administering an effective amount of sphingosine kinase inhibitors.